from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv1067c/PE_PGRS19

LFCtreatmentdescriptionclass of inhibitor

1.742

Amikacinug/mL Amikacintranslation

0.382

Cap5-10ug/mL Capreomycintranslation

1.489

Rox10-50 ug/mL Roxithromycintranslation

-0.022

SM2-5 ug/mL Streptomycintranslation

3.030

Tet5-10 ug/mL Tetracyclinetranslation

0.884

Rif0.2-5ug/mL Rifampicintranscription

-0.674

Rifp0.1-0.5ug/mL Rifapentinetranscription

0.156

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

1.425

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.195

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.220

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.818

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

1.490

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

1.207

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

1.287

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.987

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.714

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.603

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.607

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.206

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

0.347

KCN5-20 ug/mL Potassium cyaniderespiration

-0.690

NaN30.2-2 mM Sodium aziderespiration

-0.474

Nigericin50 uM Nigericinrespiration

0.530

TRC10-150 ug/mL Triclosanrespiration

0.940

TRZ10-25 ug/mL Thioridazinerespiration

1.516

Valinomycin0.5-10 uM Valinomycinrespiration

4.794

ZnSO42 mM ZnSO4respiration

-0.092

menadione6-10 ug/mL Menadionerespiration

-0.161

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.177

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.282

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.864

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.048

NRP_1Non-replicating persistence stage 1dosRassociated

-0.603

Amp0.2mg/mL AmpicillincellWall

-0.335

Cephalexin20-100 ug/mL CephalexincellWall

-0.433

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.764

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.356

EMB10-20 ug/mL EthambutolcellWall

-0.540

Eta12-40 ug/mL EthionamidecellWall

0.033

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.591

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.002

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.345

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.304

BZA0.12 mg/mL BenzamidearomaticAmides

0.287

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.179

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.288

H2O24 mM hydrogen peroxideDNAdamaging

-0.131

Levo10 ug/mL LevofloxacinDNAdamaging

-0.092

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.387

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.137

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.159

UVUV-irradiationDNAdamaging

0.764

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.421

Antimycin12.5-50 ug/mL Antimycin A?

-0.682

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.988

PA_110-50 ug/mL Antitubercular compound PA-1?

-1.302

PA_2110-50 ug/mL Antitubercular compound PA-21?

0.938

PA8240.2-2 ug/mL PA-824?

0.791

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.109

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.205

Verapamil50 uM Verapamil?

-0.184

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.670

methoxatin10-20 ug/mL Methoxatin?